0001157523-22-001662.txt : 20221122 0001157523-22-001662.hdr.sgml : 20221122 20221121173211 ACCESSION NUMBER: 0001157523-22-001662 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20221116 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20221122 DATE AS OF CHANGE: 20221121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CROSS COUNTRY HEALTHCARE INC CENTRAL INDEX KEY: 0001141103 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363] IRS NUMBER: 134066229 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-33169 FILM NUMBER: 221406844 BUSINESS ADDRESS: STREET 1: 6551 PARK OF COMMERCE BOULEVARD, N.W. CITY: BOCA RATON STATE: FL ZIP: 33487 BUSINESS PHONE: 8003472264 MAIL ADDRESS: STREET 1: 6551 PARK OF COMMERCE BOULEVARD, N.W. CITY: BOCA RATON STATE: FL ZIP: 33487 FORMER COMPANY: FORMER CONFORMED NAME: CROSS COUNTRY INC DATE OF NAME CHANGE: 20010521 8-K 1 a52975189.htm CROSS COUNTRY HEALTHCARE, INC. 8-K

UNITED STATES 
 SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 
 
 
FORM 8-K
 
 
 
CURRENT REPORT


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported) November 16, 2022
 graphic
 
 
 
Cross Country Healthcare, Inc.
(Exact name of registrant as specified in its charter)
 
 

Delaware
0-33169
13-4066229
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
 
6551 Park of Commerce Boulevard, N.W., Boca Raton, Florida 33487
(Address of Principal Executive Office) (Zip Code)

(561) 998-2232
(Registrant’s telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class Trading Symbol Name of each exchange on which registered
Common stock, par value $0.0001 per share
 CCRN
 The Nasdaq Stock Market LLC

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2).
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On November 16, 2022 the Board of Directors (the “Board”) of Cross Country Healthcare, Inc. (the “Company”) appointed Venkat Bhamidipati as a director of the Board (the “Appointment”). Mr. Bhamidipati will serve as a director until the 2023 annual meeting of stockholders or until his earlier resignation, retirement or other termination of service. The Board has determined that Mr. Bhamidipati is an independent director in accordance with the applicable rules of the Securities and Exchange Commission (the “SEC”) and the Nasdaq Stock Market. Mr. Bhamidipati will be compensated in accordance with the non-employee director compensation program of the Board, as described in the Company’s Proxy Statement filed with the SEC on April 4, 2022.

Mr. Bhamidipati, 56, was most recently Executive Vice President and the Chief Financial Officer of McAfee where he helped lead their IPO and oversaw the finance, IT, and security operations and teams that support McAfee’s business worldwide. Prior to McAfee, Venkat was an Executive Vice President and the Chief Financial Officer at Providence, a healthcare system with $25B in annual revenues, from July 2017 to September 2020. Prior to this role at Providence, Venkat spent 13 years at Microsoft from June 2004 to July 2017, where Venkat held several executive positions, including, Chief Financial Officer of the Worldwide Enterprise and Partner Group, Chief Financial Officer of the Worldwide Operations Group, and Managing Director for Business Development and Strategy. Venkat earned a Master’s degree in Commerce from Osmania University and an M.B.A in Finance and Marketing from the Kelly School of Business at Indiana University.

The Board believes that Mr. Bhamidipatis’ extensive experience as a financial executive will make him a valuable member of the Board.

Item 8.01
Other Events.

On November 21, 2022, the Company issued a press release announcing the appointment of Mr. Bhamidipati to the Board. A copy of the press release is attached to this Form 8-K as Exhibit 99.1 and is incorporated by reference herein.
  
Item 9.01
Financial Statements and Exhibits

(d) Exhibits

          
Exhibit
Description
 
 
 
 
     
  104
Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
 

 
 
CROSS COUNTRY HEALTHCARE, INC.
 
 
 
 
 
 
 
 
Dated:
November 21, 2022
By:
/s/ William J. Burns
  
 
 
 
William J. Burns
 
 
 
Executive Vice President & Chief Financial Officer

EX-99.1 2 a52975189ex99_1.htm EXHIBIT 99.1
Exhibit 99.1


Cross Country Healthcare Announces New Appointment to Board of Directors

BOCA RATON, Fla.--(BUSINESS WIRE)--November 21, 2022--Cross Country Healthcare, Inc. (NASDAQ: CCRN), a market-leading, tech-enabled workforce solutions platform and advisory firm, is pleased to announce that Venkat Bhamidipati, 56, has been elected to serve as a member of the Company's Board of Directors, November 16, 2022.

A seasoned investor and strategic advisor in technology and healthcare companies, Bhamidipati brings a deep background in finance, digital strategy, corporate development, operations, and supply chain management to Cross Country.

“Venkat is a dynamic industry leader, and we are pleased to welcome him to the board," said John A. Martins, Cross Country Healthcare president and CEO. “Venkat is joining our organization at a pivotal time; his rich business leadership and financial experience will provide important insights and contributions to the continuing success of our company."

Most recently, Bhamidipati held the role of executive vice president and chief financial officer at McAfee. In this role, Venkat oversaw the finance, IT, and security operations strategy and teams that support McAfee’s business worldwide.

Before McAfee, Venkat was executive vice president and chief financial officer at Providence, a healthcare company with $25B in annual revenues. In his previous role at Providence, he led finance and most corporate functions, including information technology, growth and corporate development, supply chain, and real estate. During his time at Providence, Venkat helped lead a comprehensive process redesign and digital transformation that helped modernize it.

Chairman of the Board of Cross Country Healthcare, Kevin C. Clark, added, "The Board and I are honored that Venkat will be joining us. His experience in healthcare and technology industries and his passion for transformation will be valuable to the company."

“I’m excited to be joining this high-performing organization and having the opportunity to work with talented and best-in-class leaders,” said Bhamidipati. “I look forward to partnering with Cross Country on their next phase of the organization’s journey.”

Venkat also spent 13 years at Microsoft, where he held several executive positions, including CFO of the Worldwide Enterprise Group, CFO of the Worldwide Operations and Technology Group, and Managing Director for Business Development and Growth Strategy. During his time at Microsoft, Venkat was also instrumental in the cloud transformation playing a pivotal leadership role.

Venkat holds an MBA in Finance and Marketing from the Kelly School of Business at Indiana University.

About Cross Country Healthcare

Cross Country Healthcare, Inc. is a leading tech-enabled workforce solutions and advisory firm with 36 years of industry experience and insight. We solve complex labor-related challenges for customers while providing high-quality outcomes and exceptional patient care. As a multi-year Best of Staffing® award winner, we are committed to an exceptionally high level of service to our clients and our homecare, education, and clinical and non-clinical healthcare professionals. Our locum tenens line of business, Cross Country Locums, has been certified by the National Committee for Quality Assurance (NCQA), the leader in healthcare accreditation, since 2001. We are the first publicly traded staffing firm to obtain The Joint Commission Certification, which we still hold with a Letter of Distinction. Cross Country Healthcare is rated as the top staffing and recruiting employer for women by InHerSights, and Certified™ by Great Place to Work®. For two consecutive years, we have received the Top Workplaces USA award and the Top Workplaces Award for Diversity, Equity & Inclusion Practices, and were recently recognized as a recipient of the Top Workplaces Awards for Innovation and Leadership by Energage, and the Women Executive Leadership Elevate Award recognizing gender diversity in our Boardroom. We have a history of investing in diversity, equality, and inclusion as a key component of the organization’s overall corporate social responsibility program, closely aligned with its core values to create a better future for its people, communities, and its stockholders.

Copies of this and other news releases as well as additional information about the Company can be obtained online at ir.crosscountryhealthcare.com. Stockholders and prospective investors can also register to automatically receive the Company's press releases, filings with the Securities and Exchange Commission (SEC), and other notices by e-mail.

Contacts

Cross Country Healthcare, Inc.
William J. Burns, Executive Vice President & Chief Financial Officer
561-237-2555
wburns@crosscountry.com

EX-101.SCH 3 ccrn-20221116.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 ccrn-20221116_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name EX-101.PRE 5 ccrn-20221116_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 cc_logo.jpg begin 644 cc_logo.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Document and Entity Information
Nov. 16, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 16, 2022
Entity Registrant Name Cross Country Healthcare, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 0-33169
Entity Tax Identification Number 13-4066229
Entity Address, Address Line One 6551 Park of Commerce Boulevard
Entity Address, Address Line Two N.W.
Entity Address, City or Town Boca Raton
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33487
City Area Code 561
Local Phone Number 998-2232
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0001141103
Title of 12(b) Security Common stock, par value $0.0001 per share
Trading Symbol CCRN
Security Exchange Name NASDAQ
XML 8 a52975189_htm.xml IDEA: XBRL DOCUMENT 0001141103 2022-11-16 2022-11-16 false 0001141103 8-K 2022-11-16 Cross Country Healthcare, Inc. DE 0-33169 13-4066229 6551 Park of Commerce Boulevard N.W. Boca Raton FL 33487 561 998-2232 Common stock, par value $0.0001 per share CCRN NASDAQ false false false false false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 1 23 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://crosscountryhealthcare.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports a52975189.htm a52975189ex99_1.htm ccrn-20221116.xsd ccrn-20221116_lab.xml ccrn-20221116_pre.xml cc_logo.jpg http://xbrl.sec.gov/dei/2021 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "a52975189.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "a52975189.htm" ] }, "labelLink": { "local": [ "ccrn-20221116_lab.xml" ] }, "presentationLink": { "local": [ "ccrn-20221116_pre.xml" ] }, "schema": { "local": [ "ccrn-20221116.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 29, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ccrn", "nsuri": "http://crosscountryhealthcare.com/20221116", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "a52975189.htm", "contextRef": "c20221116to20221116", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "a52975189.htm", "contextRef": "c20221116to20221116", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001157523-22-001662-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001157523-22-001662-xbrl.zip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end